Pipeline Moves: Lilly completes Phase II rheumatoid arthritis trial, next phase prospects rise
The Clinical Trials Arena team also investigate treatment candidates in colorectal cancer, retinal vein occlusion, and Raynaud’s disease.
By
Ophthalmology
Latest in
Ophthalmology
Innovent doses first patient in Phase I diabetic macular oedema trial
In preclinical studies, IBI324 showed to hinder angiogenesis and reduce vascular leakage.
EyePoint doses first subject in Phase II wet AMD therapy trial
The company anticipates preliminary topline findings from the trial in the second half of next year.
Clearside concludes dosing in Phase I/IIa wet AMD trial
Evaluating the safety and tolerability of CLS-AX for three months is the trial’s primary endpoint.
Sling begins subject enrolment in Phase IIb thyroid eye disease trial
The trial will analyse the safety, pharmacokinetics and efficacy of orally twice a day dose of linsitinib in TED patients.
Yuyu Pharma begins subject enrolment in Phase II dry eye disease study
The Phase II clinical study will assess the efficacy, safety, and tolerability of YP-P10 to help advance DED patients’ treatment.
HLBT engages unnamed CRO for Phase III eye disease trials with September start
These simultaneous trials will commence in September this year in the US and Europe.
EyePoint reports positive Phase I wet AMD trial data
In the trial, no cases of ocular or treatment-associated systemic serious adverse events were reported.